Doramapimod (Compound)

Synonyms:Doramapimod, 285983-48-4, BIRB-796, BIRB 796, BIRB 796 (Doramapimod), BIRB796, BIRB-796 BS, BIRB 796 BS, 3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea, 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea, 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA, HO1A8B3YVV, Doramapimod (BIRB-796), CHEMBL103667, DTXSID2048957, CHEBI:40953, MFCD09752957, 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea, 1-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea, NCGC00241104-01, 1-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea, DTXCID9028883, 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea., B96, Urea, N-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-N'-(4-(2-(4-morpholinyl)ethoxy)-1-naphthalenyl)-, CAS-285983-48-4, UNII-HO1A8B3YVV, Doramapimod (USAN/INN), Doramapimod [USAN:INN], 1-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl]urea, Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-, Kinome_2137, 1kv2, BIRB 796,Doramapimod, diaryl urea compound 10, DORAMAPIMOD [INN], DORAMAPIMOD [USAN], Doramapimod (BIRB 796), 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl)urea, BIRB 796BS, DORAMAPIMOD [WHO-DD], MLS006010153, SCHEMBL129721, BIBR-796, cid_156422, GTPL5668, BDBM13533, BIRB 0796, BIRB-0796, BCPP000333, HMS3295M15, HMS3655C07, HMS3747G11, ALBB-035131, BCP01896, BIRB-796, 3, EX-A4530, Tox21_113386, NSC785337, s1574, AKOS005256489, Tox21_113386_1, BCP9000416, CCG-264915, CS-0219, DB03044, NSC-785337, SB16634, 1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea, NCGC00241104-02, NCGC00241104-07, 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea, AC-24379, AS-19375, HY-10320, SMR004458704, US8933228, BIRB 796, FT-0667779, SW219700-1, D03736, A819503, SR-00000002531, Q-101419, SR-00000002531-1, BRD-K74065929-001-01-5, Q27077098, p38 MAP Kinase Inhibitor X, BIRB 796 - CAS 285983-48-4, CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C, 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea, 1-[5-tert-butyl-2-(4-methylphenyl)-3-pyrazolyl]-3-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea, 3-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea, Doramapimod1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea, N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]- N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-urea, N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea, N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea

Id:156422

Description:nan